checkmate-8hw: nivolumab and ipilimumab in msi-h/dmmr mcrc
Published 3 months ago • 81 plays • Length 1:11Download video MP4
Download video MP3
Similar videos
-
2:02
hrqol findings from checkmate 8hw: nivolumab and ipilimumab in msi-h/dmmr mcrc
-
2:00
checkmate 8hw: first-line nivolumab plus ipilimumab in msi-h/dmmr mcrc
-
0:59
checkmate 8hw: hrqol outcomes of nivolumab and ipilimumab in msi-h/dmmr mcrc
-
0:43
keynote-177 and checkmate 8hw: promising first-line immunotherapy for msi-h mcrc
-
0:43
immunotherapy in msi-h/dmmr mcrc: first-line options and dual checkpoint inhibition insights
-
2:03
promising checkmate-142 data for second-line ipilimumab plus nivolumab in mcrc
-
1:54
dr. lenz on updated data from checkmate 142 with nivolumab ipilimumab in mcrc
-
2:33
updated results for nivolumab in msi-h colorectal cancer
-
5:10
checkmate 214: patterns of progression with nivolumab plus ipilimumab versus sunitinib for rcc
-
0:55
molecular testing for the evaluation of colorectal cancer
-
4:58
long-term results from checkmate 040: nivolumab ipilimumab in advanced hcc
-
5:22
checkmate 743: first-line nivolumab plus ipilimumab vs chemotherapy in patients with unresectabl...
-
1:58
dr. plimack on significance of checkmate-025 trial in rcc
-
1:17
dr. hammers on the checkmate-214 study for rcc
-
1:58
dr. heymach discusses the checkmate-026 study in lung cancer
-
4:31
checkmate142: checkpoint combination therapy in first-line colorectal cancer
-
1:18
how can we mitigate health inequalities in colorectal cancer?
-
3:59
checkmate 067 - combined nivolumab and ipilimumab
-
6:03
checkmate 9la: nivolumab, ipilimumab and chemotherapy for stage iv nsclc